USPTO Examiner EDWARDS PHILIP CHARLES - Art Unit 3792

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18810425SYSTEM AND METHODS FOR RESIDUAL LIMBS OF AMPUTEESAugust 2024February 2025Allow610YesNo
18836090VENTRICULAR ASSIST SYSTEM AND METHOD OF TREATMENT OF CARDIOVASCULAR IMPAIRMENTAugust 2024June 2025Allow1020YesNo
18679893Electrically based medical treatment device and methodMay 2024December 2024Allow710NoNo
18439568DEVICE AND METHOD FOR UNATTENDED TREATMENT OF A PATIENTFebruary 2024August 2024Allow610NoNo
18389119DEVICES AND METHODS FOR REMOTE THERAPY AND PATIENT MONITORINGNovember 2023September 2024Allow1020YesNo
18234456Antiviral Digital DeviceAugust 2023January 2024Allow510YesNo
18363478DEVICE AND METHOD FOR UNATTENDED TREATMENT OF A PATIENTAugust 2023January 2025Allow1810NoNo
18363405Prescribed Neuromodulation Dose DeliveryAugust 2023June 2025Allow2220YesNo
18262186A CLOSED-LOOP ADAPTIVE AC STIMULATION NEURAL NETWORK REGULATION METHOD AND SYSTEMJuly 2023February 2024Allow710NoNo
18326171SYSTEMS AND METHODS FOR PROVIDING PERSONALIZED TARGETED NON-INVASIVE STIMULATION TO A BRAIN NETWORKMay 2023April 2024Allow1011YesNo
18311232METHOD FOR TREATING ERECTILE AND SEXUAL DYSFUNCTION WITH FOCUSED EXTRACORPOREAL SHOCKWAVE THERAPYMay 2023September 2023Allow510NoNo
18187624SYSTEMS AND METHODS FOR MANAGED TRAINING AND REHABILITATION VIA ELECTRICAL STIMULATIONMarch 2023July 2023Allow410NoNo
18170284DEVICE AND METHOD FOR UNATTENDED TREATMENT OF A PATIENTFebruary 2023October 2023Allow811NoNo
18106668DETERMINING HEART RATE WITH REFLECTED LIGHT DATAFebruary 2023December 2024Allow2220NoNo
18154373CATHETER PUMPJanuary 2023March 2025Allow2620YesNo
18150177METHODS AND APPARATUSES FOR REDUCING BLEEDING VIA COORDINATED TRIGEMINAL AND VAGAL NERVE STIMULATIONJanuary 2023June 2023Allow510NoNo
17987471PERIPHERAL NERVE STIMULATION FOR RLS OR PLMD WITH SENSORS FOR MONITORING OF SLEEP-RELATED DATANovember 2022September 2023Allow1010NoNo
17930888DEVICE AND METHOD FOR UNATTENDED TREATMENT OF A PATIENTSeptember 2022March 2023Allow610YesNo
17941568DEVICE AND METHOD FOR UNATTENDED TREATMENT OF A PATIENTSeptember 2022July 2023Allow1111NoNo
17887661SYSTEMS, METHODS AND DEVICES FOR ELECTRICAL STIMULATION THERAPYAugust 2022August 2023Allow1220YesNo
17887630SYSTEMS, METHODS AND DEVICES FOR ELECTRICAL STIMULATION THERAPYAugust 2022August 2023Allow1220YesNo
17880500METHODS FOR TRANSCUTANEOUS FACIAL NERVE STIMULATION AND APPLICATIONS THEREOFAugust 2022April 2023Allow810YesNo
17874364DEVICES AND METHODS FOR REMOTE THERAPY AND PATIENT MONITORINGJuly 2022August 2023Allow1220NoNo
17867184IMPLANTABLE MEDICAL DEVICES, AND METHODS OF USE THEREWITH, THAT DETECT MRI SYSTEMS WITH ENHANCED SPECIFICITYJuly 2022March 2025Allow3200NoNo
17834281HEALTH-MONITOR PATCHJune 2022November 2024Abandon2910NoNo
17664161DEVICE AND METHOD FOR UNATTENDED TREATMENT OF A PATIENTMay 2022October 2023Allow1711NoNo
17740852Diagnosis and Treatment of Gastrointestinal Dysfunction Via Implantation of Temporary and Permanent Electrical StimulatorsMay 2022June 2024Allow2610NoNo
17738622CHARGING-INDUCED IMPLANT OPERATIONMay 2022June 2025Allow3710NoNo
17661406DEVICE AND METHOD FOR UNATTENDED TREATMENT OF A PATIENTApril 2022July 2022Allow300NoNo
17686405ELECTRICALLY BASED MEDICAL TREATMENT DEVICE AND METHODMarch 2022September 2024Abandon3110NoNo
17667051ELECTRICAL TREATMENT OF ALZHEIMER'S DISEASEFebruary 2022April 2022Allow200NoNo
17583990VARIABLE OPERATING POINT NEURAL ELECTROSTIMULATION SUCH AS TO TREAT RLSJanuary 2022January 2025Allow3610NoNo
17582920SYSTEM FOR IMPROVING NEUROSTIMULATION TREATMENT COMPLIANCE WITH GAMIFICATIONJanuary 2022February 2025Allow3710NoNo
17578339METHODS AND APPARATUSES FOR REDUCING BLEEDING VIA COORDINATED TRIGEMINAL AND VAGAL NERVE STIMULATIONJanuary 2022September 2024Allow3210NoNo
17576646DEVICE AND METHOD FOR UNATTENDED TREATMENT OF A PATIENTJanuary 2022November 2024Allow3410NoNo
17565982SYSTEMS AND METHODS FOR PATIENT-ENABLED BLADDER CONTROLDecember 2021February 2025Allow3811NoNo
17564294WELLNESS DEVICE USING INTERFERENCE FREQUENCIESDecember 2021July 2022Allow610YesNo
17619950MOTION-ACTIVATED, CLOSED-LOOP NON-INVASIVE VAGUS NERVE STIMULATION FOR NEUROREHABILITATIONDecember 2021June 2023Allow1821YesNo
17542032VENTRICULAR ASSIST DEVICE AND CARDIAC ELECTRICAL STIMULATION SYSTEM FOR THERAPY CONTROLDecember 2021September 2024Allow3410NoNo
17523753SYSTEMS, DEVICES, AND METHODS FOR ELECTRICAL STIMULATION USING FEEDBACK TO ADJUST STIMULATION PARAMETERSNovember 2021November 2024Allow3620YesNo
17514551DEVICES AND METHODS FOR REMOTE THERAPY AND PATIENT MONITORINGOctober 2021April 2022Allow610NoNo
17506851SYSTEMS, METHODS AND DEVICES FOR ELECTRICAL STIMULATION THERAPYOctober 2021May 2022Allow720YesNo
17503882Biocompatible HousingOctober 2021June 2024Allow3210NoNo
17480861NON-INVASIVE NEURAL INTERFACESeptember 2021July 2024Allow3410NoNo
17440005GARMENT PAIRED WITH A LEG CONTRACTION IMPULSE DEVICE THAT IS TRIGGERED BY WALKINGSeptember 2021April 2025Abandon4320NoNo
17468296SIGNAL COLOR MORPHOLOGYSeptember 2021June 2025Allow4530NoNo
17400306SYSTEM AND METHOD FOR LOCATING AN IMPLANTATION SITE IN THE BRAINAugust 2021August 2024Allow3640YesNo
17390156Customized electrical stimulation providing system and method thereofJuly 2021August 2024Allow3710NoNo
17389551PERIPHERAL NERVE STIMULATION FOR RESTLESS LEGS SYNDROMEJuly 2021August 2024Allow3720YesNo
17379591Neuromodulation System and Method with Feedback Optimized Electrical Field GenerationJuly 2021September 2024Allow3830NoNo
17365244DEVICE FOR THE TRANSCUTANEOUS ELECTRICAL STIMULATION OF THE TRIGEMINAL NERVEJuly 2021October 2024Allow3910NoNo
17360779METHOD FOR DETERMINING OPERATIONAL PARAMETERS OF A BLOOD PUMPJune 2021December 2023Allow3000NoNo
17417345EVOKED RESPONSE-BASED SYSTEMS AND METHODS FOR DETERMINING ELECTRODE POSITIONING WITHIN A COCHLEAJune 2021June 2025Allow4820YesNo
17351045WEARABLE CARDIOVERTER DEFIBRILLATOR (WCD) SYSTEM HAVING MAIN UI THAT CONVEYS MESSAGE AND PERIPHERAL DEVICE THAT AMPLIFIES THE MESSAGEJune 2021June 2024Allow3610NoNo
17318824DEVICES AND METHODS FOR DETERMINING THE EFFECTIVENESS OF ELECTRICAL STIMULATIONMay 2021March 2024Allow3410NoNo
17313619SYSTEMS AND METHODS FOR TARGETED SACRAL NERVE STIMULATIONMay 2021April 2024Allow3610NoNo
17306032INTERVENTIONAL MEDICAL DEVICES, DEVICE SYSTEMS, AND FIXATION COMPONENTS THEREOFMay 2021November 2024Allow4221YesNo
17243633BIPHASIC NEURAL STIMULATION TO IMPROVE CEREBRAL CONDUCTION SPEED AND MITOCHONDRIAL FUNCTIONINGApril 2021January 2023Allow2010NoNo
17241924VARIABLE OPERATING POINT NEURAL ELECTROSTIMULATION SUCH AS TO TREAT RLSApril 2021October 2021Allow610NoNo
17226948SYSTEMS AND METHODS FOR TREATING OR SUPPORTING HUMAN JOINTS OR A PORTION OF THE HUMAN BODYApril 2021July 2024Allow3921YesNo
17209004BIOELECTRIC DEVICES FOR USE ON SPECIFIC AREAS OF THE BODYMarch 2021February 2024Allow3510NoNo
17205571PATIENT THERAPY SYSTEMS AND METHODSMarch 2021August 2024Abandon4110NoNo
17249775SYSTEMS FOR IMPROVING NEUROSTIMULATION COMPLIANCE USING A PATIENT INTERFACE MODULEMarch 2021September 2021Allow610NoNo
17186858FAST IDENTIFICATION OF SHOCKABLE OR NON-SHOCKABLE RHYTHMS IN ECG DATAFebruary 2021July 2024Allow4120YesNo
17176691Constipation and Fecal Incontinence Treatment SystemFebruary 2021December 2023Abandon3430NoNo
17174033ELECTRO-STIMULATION SYSTEMS AND METHODS FOR REHABILITATION AND TREATMENT OF SEXUAL DISORDERSFebruary 2021August 2021Allow620NoNo
17170424DUAL MULTIPOLAR LEAD IMPLANTABLE IN THE CORONARY VENOUS NETWORKFebruary 2021March 2024Allow3710NoNo
17163311HIGH EFFICIENCY BLOOD PUMPJanuary 2021May 2024Allow4011NoNo
17129498METHOD AND APPARATUS FOR PORTABLY TREATING MUSCULAR DISCOMFORTDecember 2020June 2023Allow2910YesNo
17123008IMPLANTABLE STIMULATOR WITH AN ELECTRODE ARRAY AND CONFORMABLE SUBSTRATEDecember 2020March 2022Abandon1520YesNo
17111950Neuromodulation System and Method with Feedback Optimized Electrical Field GenerationDecember 2020June 2021Allow610NoNo
17112791MOTOR ASSEMBLY FOR CATHETER PUMPDecember 2020June 2024Allow4320NoNo
17106563MOTOR ASSEMBLY FOR CATHETER PUMPNovember 2020September 2023Allow3310NoNo
17106559MOTOR ASSEMBLY FOR CATHETER PUMPNovember 2020November 2023Allow3610NoNo
17107469MOTOR ASSEMBLY FOR CATHETER PUMPNovember 2020November 2023Allow3510NoNo
17107580MOTOR ASSEMBLY FOR CATHETER PUMPNovember 2020December 2023Allow3710NoNo
17107550MOTOR ASSEMBLY FOR CATHETER PUMPNovember 2020December 2023Allow3710NoNo
16949884METHOD OF INCREASING THORACIC ROTATION RANGE OF MOTIONNovember 2020October 2022Abandon2310NoNo
17056842Method and Device for Treating Sleep Related Breathing DisordersNovember 2020October 2022Allow2210NoNo
17097239PORTABLE COMPLEX SENSOR DEVICE FOR MEASURING MULTIPLE ITEMS OF BIOMETRIC INFORMATION, AND MEASUREMENT METHODNovember 2020September 2023Allow3400NoNo
17085874COLLAPSIBLE AND SELF-EXPANDING CANNULA FOR A PERCUTANEOUS HEART PUMP AND METHOD OF MANUFACTURINGOctober 2020February 2024Allow4050YesNo
17050788Neurostimulation of Mixed NervesOctober 2020November 2023Allow3710YesNo
17069193NERVE STIMULATING APPARATUS, BIOMETRIC INFORMATION MEASURING SYSTEM, AND METHOD OF SETTING STIMULUS GENERATING TIMINGS OF BIOMETRIC INFORMATION MEASURING SYSTEMOctober 2020March 2023Allow2910NoNo
17045429Systems and Methods for Delivering Non-Invasive Neuromodulation to Reduce the Effects of Shock and Traumatic Brain Injury in Animals and Humans and to Prolong LifeOctober 2020March 2022Allow1810NoNo
17062010PERIPHERAL NERVE STIMULATION FOR RESTLESS LEGS SYNDROMEOctober 2020April 2021Allow710NoNo
17061523ELECTRICALLY BASED MEDICAL TREATMENT DEVICE AND METHODOctober 2020March 2022Allow1810NoNo
17043757EXTERNAL STIMULUS APPLICATION SYSTEM, EXTERNAL STIMULUS CONDITION DETERMINATION SYSTEM, AND EXTERNAL STIMULUS CONDITION DETERMINATION SUPPORT SERVERSeptember 2020February 2024Allow4011NoNo
17035689DEVICES AND METHODS FOR DELIVERING MECHANICAL STIMULATION TO NERVE, MECHANORECEPTOR, AND CELL TARGETSSeptember 2020July 2022Allow2110YesNo
16981505Brain Rebalancing Through Acoustic and Electric MirroringSeptember 2020May 2023Allow3200NoNo
17016426IMPLANTABLE STIMULATOR WITH A CONFORMABLE FOIL-LIKE ELECTRODE ARRAYSeptember 2020April 2021Allow711YesNo
17016734Detection and Treatment of Obstructive Sleep ApneaSeptember 2020June 2022Allow2110NoNo
17013396SYSTEMS AND METHODS FOR PERIPHERAL NERVE STIMULATION TO TREAT TREMOR WITH DETACHABLE THERAPY AND MONITORING UNITSSeptember 2020March 2024Allow4320NoNo
17010488METHOD AND APPARATUS FOR DELIVERING ANTI-TACHYCARDIA PACINGSeptember 2020June 2022Allow2110NoNo
17009525MONITORING BLADDER DYSFUNCTION USING A PROBABILITY FUNCTIONSeptember 2020May 2023Allow3230YesNo
16970842METHODS AND SYSTEMS FOR NERVE CONDUCTION BLOCKAugust 2020June 2023Allow3410YesNo
16993684ATRIAL TRACKING CONFIRMATION IN AN INTRACARDIAC VENTRICULAR PACEMAKERAugust 2020April 2023Allow3210NoNo
16985530Apparatus and Method for Treating Obstructive Sleep ApneaAugust 2020July 2023Allow3520YesNo
16965898ELECTRICAL STIMULATION SYSTEM AND METHODS FOR LIMB CONTROLJuly 2020April 2023Abandon3201NoNo
16932554OCCLUSION THERAPY AND PELVIC STIMULATION SYSTEMJuly 2020November 2023Abandon4021NoNo
16922304METHODS AND SYSTEMS FOR DISEASE TREATMENT USING ELECTRICAL STIMULATIONJuly 2020August 2023Allow3730YesNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner EDWARDS, PHILIP CHARLES.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
1
Examiner Affirmed
0
(0.0%)
Examiner Reversed
1
(100.0%)
Reversal Percentile
99.6%
Higher than average

What This Means

With a 100.0% reversal rate, the PTAB has reversed the examiner's rejections more often than affirming them. This reversal rate is in the top 25% across the USPTO, indicating that appeals are more successful here than in most other areas.

Strategic Value of Filing an Appeal

Total Appeal Filings
7
Allowed After Appeal Filing
3
(42.9%)
Not Allowed After Appeal Filing
4
(57.1%)
Filing Benefit Percentile
69.2%
Higher than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 42.9% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is above the USPTO average, suggesting that filing an appeal can be an effective strategy for prompting reconsideration.

Strategic Recommendations

Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.

Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Examiner EDWARDS, PHILIP CHARLES - Prosecution Strategy Guide

Executive Summary

Examiner EDWARDS, PHILIP CHARLES works in Art Unit 3792 and has examined 293 patent applications in our dataset. With an allowance rate of 92.5%, this examiner allows applications at a higher rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 25 months.

Allowance Patterns

Examiner EDWARDS, PHILIP CHARLES's allowance rate of 92.5% places them in the 78% percentile among all USPTO examiners. This examiner is more likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by EDWARDS, PHILIP CHARLES receive 1.28 office actions before reaching final disposition. This places the examiner in the 24% percentile for office actions issued. This examiner issues significantly fewer office actions than most examiners.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by EDWARDS, PHILIP CHARLES is 25 months. This places the examiner in the 70% percentile for prosecution speed. Prosecution timelines are slightly faster than average with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a +3.9% benefit to allowance rate for applications examined by EDWARDS, PHILIP CHARLES. This interview benefit is in the 25% percentile among all examiners. Recommendation: Interviews provide a below-average benefit with this examiner.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 42.5% of applications are subsequently allowed. This success rate is in the 93% percentile among all examiners. Strategic Insight: RCEs are highly effective with this examiner compared to others. If you receive a final rejection, filing an RCE with substantive amendments or arguments has a strong likelihood of success.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 40.5% of cases where such amendments are filed. This entry rate is in the 55% percentile among all examiners. Strategic Recommendation: This examiner shows above-average receptiveness to after-final amendments. If your amendments clearly overcome the rejections and do not raise new issues, consider filing after-final amendments before resorting to an RCE.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 83.3% of appeals filed. This is in the 75% percentile among all examiners. Of these withdrawals, 40.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.

Petition Practice

When applicants file petitions regarding this examiner's actions, 27.5% are granted (fully or in part). This grant rate is in the 19% percentile among all examiners. Strategic Note: Petitions are rarely granted regarding this examiner's actions compared to other examiners. Ensure you have a strong procedural basis before filing a petition, as the Technology Center Director typically upholds this examiner's decisions.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 44% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 43% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • RCEs are effective: This examiner has a high allowance rate after RCE compared to others. If you receive a final rejection and have substantive amendments or arguments, an RCE is likely to be successful.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.